Immune microenvironment of Epstein-Barr virus (EBV)-negative compared to EBV-associated gastric cancers: implications for immunotherapy.
Saved in:
| Title: | Immune microenvironment of Epstein-Barr virus (EBV)-negative compared to EBV-associated gastric cancers: implications for immunotherapy. |
|---|---|
| Authors: | McMiller TL; Department of Surgery, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; Bloomberg-Kimmel Institute for Cancer Immunotherapy and Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Besharati S; Department of Pathology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Yarchoan M; Bloomberg-Kimmel Institute for Cancer Immunotherapy and Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; Department of Oncology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Zhu Q; Department of Oncology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Ünsal-Kaçmaz K; Bristol Myers Squibb Co, Princeton, New Jersey, USA., Xu K; Bristol Myers Squibb Co, Princeton, New Jersey, USA., Lee J; Department of Surgery, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; Bloomberg-Kimmel Institute for Cancer Immunotherapy and Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Bhaijee F; Department of Pathology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Engle LL; Bloomberg-Kimmel Institute for Cancer Immunotherapy and Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; Department of Dermatology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Taube JM; Bloomberg-Kimmel Institute for Cancer Immunotherapy and Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; Department of Dermatology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Berger AE; Department of Surgery, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; Bloomberg-Kimmel Institute for Cancer Immunotherapy and Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Anders RA; Bloomberg-Kimmel Institute for Cancer Immunotherapy and Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; Department of Pathology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Topalian SL; Department of Surgery, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA stopali1@jhmi.edu.; Bloomberg-Kimmel Institute for Cancer Immunotherapy and Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. |
| Source: | Journal for immunotherapy of cancer [J Immunother Cancer] 2024 Nov 20; Vol. 12 (11). Date of Electronic Publication: 2024 Nov 20. |
| Publication Type: | Journal Article; Comparative Study; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S. |
| Journal Info: | Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
